US 8039001
Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
granted A61KA61K2039/5256A61K2039/5258
Quick answer
US patent 8039001 (Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection) held by The Regents of the University of Colorado, a Body Corporate expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K2039/5256, A61K2039/5258, A61K2039/585, A61K39/12